Abiopharma

(90% Positive) Syndax Pharmaceuticals Inc (SNDX) Announces Enrollment Update for acceleration Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

New Form DFAN14A - Avidity Biosciences, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002891 Size: 33 KB

Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026

(99% Neutral) RxSight Inc. (RXST) Reports Q1 2026 Financial Results

(10% Negative) Zymeworks Inc (ZYME) Announces Delay in Ziihera Development Timeline Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

📋 DAVID J BORGES (Officer) plans to sell 30K shares of OMEROS CORPORATION (at $12.72 each, total $382K) Filed: Jan 12, 2026 | ID: 000358

Douglass Brian Robb 🟢 acquired 4.4K shares (1 derivative) of REPLIGEN CORP (RGEN) at $163.86 Transaction Date: Dec 31, 2025 | Filing ID: 010470

Scorpius Holdings Inc. (SCPX) Files Form 10-Q

(99% Neutral) Option Care Health Inc (OPCH) Reports Q1 2026 Financial Results

New Form DEFA14A - Avidity Biosciences, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010464 Size: 42 KB

(99% Neutral) GeoVax Labs Inc. (GOVX) Announces Executive Changes

New Form 3 - REPLIGEN CORP Filed: 2026-01-12 AccNo: 0001193125-26-010463 Size: 22 KB

Thermo Fisher Scientific - Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

(99% Positive) Allurion Technologies Inc (ALUR) Provides Update on results for metabolically healthy weight loss

(99% Neutral) BioAtla Inc (BCAB) Announces Business Combination